Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
111 Inc - ADR - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES
Ticker
Exchange
SIC #
Website
Latest Ticker
YI
Nasdaq
5122
http://gangling.111.com.cn/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 111 Inc - ADR
111, Inc. (NASDAQ:YI) Q4 2023 Earnings Call Transcript
- Mar 22nd, 2024 3:36 pm
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
- Mar 21st, 2024 8:47 am
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
- Mar 1st, 2024 9:00 am
111 Announces Receipt of Withdrawal of Going Private Proposal
- Feb 27th, 2024 1:58 pm
111, Inc. (NASDAQ:YI) Q3 2023 Earnings Call Transcript
- Dec 1st, 2023 2:20 pm
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
- Nov 30th, 2023 6:00 am
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow
- Nov 13th, 2023 5:10 am
111, Inc. (NASDAQ:YI) Q2 2023 Earnings Call Transcript
- Aug 31st, 2023 12:09 pm
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
- Aug 24th, 2023 6:00 am
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow
- Jul 31st, 2023 9:59 am
111, Inc. Announces First Quarter 2023 Unaudited Financial Results
- Jun 15th, 2023 5:15 am
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
- May 25th, 2023 6:05 am
Scroll